$148 Million is the total value of DCF Advisers, LLC's 67 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 43.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | Sell | ABBVIE INC | $11,635,920 | +13.9% | 72,000 | -5.4% | 7.86% | +19.2% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $8,268,750 | +7.1% | 156,250 | -5.9% | 5.59% | +12.0% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $7,864,241 | +3.3% | 10,900 | -1.4% | 5.32% | +8.1% |
| MU | Sell | MICRON TECHNOLOGY INC | $7,746,900 | -11.6% | 155,000 | -11.4% | 5.24% | -7.6% |
| XNCR | Sell | XENCOR INC | $5,363,537 | -10.9% | 205,973 | -11.1% | 3.62% | -6.8% |
| T | Sell | AT&T INC | $2,623,425 | -12.3% | 142,500 | -26.9% | 1.77% | -8.2% |
| AAPL | Sell | APPLE INC | $1,916,468 | -49.1% | 14,750 | -45.9% | 1.30% | -46.8% |
| TPB | Sell | TURNING PT BRANDS INC | $1,797,734 | -0.2% | 83,113 | -2.0% | 1.22% | +4.4% |
| ALT | Sell | ALTIMMUNE INC | $1,327,186 | -54.6% | 80,680 | -64.8% | 0.90% | -52.5% |
| IMPL | Sell | IMPEL NEUROPHARMA INC | $1,221,844 | -46.5% | 325,825 | -30.6% | 0.83% | -44.0% |
| LNSR | Sell | LENSAR INC | $1,023,396 | -48.5% | 345,742 | -3.5% | 0.69% | -46.1% |
| NFLX | Sell | NETFLIX INC | $1,002,592 | -3.2% | 3,400 | -22.7% | 0.68% | +1.3% |
| MRVL | Sell | MARVELL TECHNOLOGY INC | $648,200 | -41.9% | 17,500 | -32.7% | 0.44% | -39.3% |
| PYPL | Sell | PAYPAL HLDGS INC | $498,540 | -42.1% | 7,000 | -30.0% | 0.34% | -39.4% |
| DXC | Sell | DXC TECHNOLOGY CO | $490,250 | -14.7% | 18,500 | -21.3% | 0.33% | -10.8% |
| C | Sell | CITIGROUP INC | $452,300 | -85.5% | 10,000 | -86.7% | 0.31% | -84.8% |
| MCHI | Sell | ISHARES TRmsci china etf | $397,005 | -70.9% | 8,358 | -73.9% | 0.27% | -69.5% |
| NEM | Sell | NEWMONT CORP | $354,000 | -57.9% | 7,500 | -62.5% | 0.24% | -56.0% |
| FB | Sell | META PLATFORMS INCcl a | $270,765 | -77.8% | 2,250 | -75.0% | 0.18% | -76.8% |
| AIRT | Sell | AIR T INC | $266,927 | +39.0% | 10,798 | -3.8% | 0.18% | +45.2% |
| PEO | Sell | ADAM NAT RES FD INC | $218,000 | -17.1% | 10,000 | -25.9% | 0.15% | -13.5% |
| OVID | Sell | OVID THERAPEUTICS INC | $130,691 | -56.3% | 70,264 | -56.8% | 0.09% | -54.4% |
| KIRK | Sell | KIRKLANDS INC | $89,876 | -71.6% | 27,235 | -74.1% | 0.06% | -70.1% |
| PSFE | Exit | PAYSAFE LIMITEDord | $0 | – | -16,760 | -100.0% | -0.02% | – |
| TLT | Exit | ISHARES TRcall | $0 | – | -2,000 | -100.0% | -0.13% | – |
| GAM | Exit | GENERAL AMERN INVS CO INC | $0 | – | -6,250 | -100.0% | -0.14% | – |
| INTC | Exit | INTEL CORP | $0 | – | -10,000 | -100.0% | -0.17% | – |
| EOG | Exit | EOG RES INC | $0 | – | -3,000 | -100.0% | -0.22% | – |
| GLD | Exit | SPDR GOLD TRcall | $0 | – | -2,500 | -100.0% | -0.25% | – |
| FXY | Exit | INVESCO CURRENCYSHARES JAPANjapanese yen | $0 | – | -6,750 | -100.0% | -0.28% | – |
| KWEB | Exit | KRANESHARES TRcsi chi internet | $0 | – | -22,500 | -100.0% | -0.36% | – |
| MU | Exit | MICRON TECHNOLOGY INCput | $0 | – | -11,500 | -100.0% | -0.37% | – |
| FXY | Exit | INVESCO CURRENCYSHARES JAPANput | $0 | – | -10,000 | -100.0% | -0.42% | – |
| INTC | Exit | INTEL CORPcall | $0 | – | -27,500 | -100.0% | -0.46% | – |
| HYG | Exit | ISHARES TRiboxx hi yd etf | $0 | – | -17,500 | -100.0% | -0.81% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -10,000 | -100.0% | -1.06% | – |
| PRTA | Exit | PROTHENA CORP PLCput | $0 | – | -27,500 | -100.0% | -1.08% | – |
| AAPL | Exit | APPLE INCput | $0 | – | -15,000 | -100.0% | -1.34% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -157,665 | -100.0% | -1.54% | – |
| GDX | Exit | VANECK VECTORS ETF TRgold miners etf | $0 | – | -102,500 | -100.0% | -1.60% | – |
| PRTA | Exit | PROTHENA CORP PLCcall | $0 | – | -52,500 | -100.0% | -2.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.